Recent developments in immunotherapy for gastrointestinal tract cancers

Abstract The past few decades have witnessed the rise of immunotherapy for Gastrointestinal (GI) tract cancers. The role of immune checkpoint inhibitors (ICIs), particularly programmed death protein 1 (PD-1) and PD ligand-1 antibodies, has become increasingly pivotal in the treatment of advanced and...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, Wenfei Li, Lin Cong, Jialin Lu, Liyang Mo, Huizhen Liu, Siyi He, Chao Yu, Zhiruo Zhou, Boya Wang, Yanshuo Cao, Zhenghang Wang, Lin Shen, Yakun Wang, Xiaotian Zhang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2024-08-01
Sarja:	Journal of Hematology & Oncology
Aiheet:	Gastrointestinal tract cancers Immunotherapy Biomarkers Resistance Precise treatment
Linkit:	https://doi.org/10.1186/s13045-024-01578-x
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!